FDA deals Ocugen a major setback that will delay the company's Covid-19 vaccine plans
June 11, 2021 at 09:27 AM EDT
Ocugen now faces a longer FDA review period as it works to bring a Covid vaccine approved in India to the United States.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|